VALNEVA
Live / Registered — Registered — Section 71 accepted (as of 09 May 2025)
What this means for you
Registered since 17 Feb 2015. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79138125
- Registration number
- 4686292
- Mark type
- Stylized text
- Filed
- 31 May 2013
- Published for opposition
- 02 Dec 2014
- Registered
- 17 Feb 2015
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 001 — Chemicals: Chemicals for use in industry, science and agriculture, except fungicides, herbicides, insecticides and parasiticides; molecules from biotechnologies, namely, proteins in raw material for industrial use, scientific or medical research; cells and cell lines for use in scientific, laboratory, or medical research; nucleic acids for laboratory use; proteins in raw material form for scientific and medical research; recombinant proteins in raw material form for scientific and medical research; Biomedical compounds, namely, peptide substrates and peptide antigens used in analyzing and detecting certain toxins for clinical or medical laboratory use; Biochemical preparations derived from blood serum used as growth promoters in tissue cultures and microbiological media; Biochemicals, namely, antibodies and fragments thereof for in vitro scientific or research use; Chemicals for use in biotechnological product development; Cultures of microorganisms other than for medical and veterinary use; Biological preparations and bacteriological preparations for use in cell cultures other than for medical or veterinary use
- Class 005 — Pharmaceuticals: Pharmaceuticals for human and veterinary use for the treatment of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; antibodies and fragments thereof for use in disease testing; cell cultures, microorganisms and viruses for medical and veterinary use; diagnostic agents for medical, pharmaceutical and veterinary use; cells for medical or clinical use; culture media for cultivating microorganism cells for medical and veterinary use; adjuvants for medical or and veterinary use; pharmaceutical and veterinary preparations for medical, pharmaceutical and veterinary use, namely, preparations of encapsulated cells which release antibodies, living cells and microorganisms, vaccines, viral vectors, proteins, peptides, enzymes, nucleic acids or pharmaceutically active compounds for the treatment of cancer, auto-immune disorders, infectious diseases, inflammatory diseases, neurological and genetic disorders, bowel diseases, and digestion problems
- Class 042 — Scientific and technological services: Scientific research services for medical purposes in the fields of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; scientific research for medical, pharmaceutical and veterinary purposes in the fields of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; scientific research, in particular, in the fields of biology, cellular and molecular biology, biotechnology, bacteriology, immunology, genetics, medicine, pharmacology, virology, chemistry; scientific research relating to vaccines, antibiotics and immunological products for human and veterinary use; research and development of new products for others; testing, analysis, and evaluation of the goods of others to assure compliance with industry standards in the scientific, medical and veterinary fields; development and design of laboratory instruments for scientific and industrial research, in particular, to obtain and prepare cells, cell lines, viruses, proteins, animal and human materials; development of vaccines, antibiotics and immunological products for human and veterinary use; scientific and technological services, namely, diagnostic and prognostic analyses in the fields of cells, cell lines, animal and human materials, microorganisms, molecules for scientific purposes; scientific research, namely, preparation of scientific experts opinions reports
Owner
Prosecution history
- 09 May 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 09 May 2025 — REGISTERED-SEC.71 ACCEPTED
- 05 May 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Dec 2024 — TEAS SECTION 71 RECEIVED
- 22 May 2024 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 25 Apr 2024 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 25 Feb 2024 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
- 17 Feb 2024 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
- 17 Feb 2024 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 07 Apr 2023 — INTERNATIONAL REGISTRATION RENEWED
- 03 Nov 2022 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 15 Oct 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 01 Oct 2022 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
- 30 Nov 2020 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 30 Nov 2020 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.